• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Vaxon Biotech - Articles and news items

opdivo

Vaxon completes enrolment in Phase IIb trial of Vx-001 in NSCLC

Industry news / 16 March 2016 / Victoria White

Vx-001 is a therapeutic cancer vaccine based on proprietary antigens known as optimised cryptic tumour peptides…

 

Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionWATCH NOW
+ +